Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · IEX Real-Time Price · USD
3.800
-0.250 (-6.17%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $20.63 million as of July 2, 2024. Its market cap has increased by 76.37% in one year.
Market Cap
20.63M
Enterprise Value
-11.78M
1-Year Change
76.37%
Ranking
Category
Stock Price
$3.80
Market Cap Chart
Since October 3, 2019, Aprea Therapeutics's market cap has decreased from $393.80M to $20.63M, a decrease of -94.76%. That is a compound annual growth rate of -46.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 21.90M | 24.43% |
| Dec 29, 2023 | 17.60M | 0.57% |
| Dec 30, 2022 | 17.50M | -71.59% |
| Dec 31, 2021 | 61.60M | -40.88% |
| Dec 31, 2020 | 104.20M | -89.18% |
| Dec 31, 2019 | 963.30M | 144.62% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inspira Technologies Oxy B.H.N. | 22.39M |
| Unity Biotechnology | 22.33M |
| OneMedNet | 22.25M |
| Nephros | 22.25M |
| Minerva Neurosciences | 22.12M |
| NanoViricides | 21.86M |
| Spruce Biosciences | 21.85M |
| AIM ImmunoTech | 21.35M |